Molecular Imaging Using Radiolabeled Atezolizumab to Assess Atezolizumab Biodistribution in Lymphoma Patients

NCT03850028 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Closed prematurely because the accrual was not achieved

Conditions

Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

Interventions

OTHER: 89Zr-atezolizumab PET scans

Sponsor

University Medical Center Groningen

Collaborators

[object Object]
[object Object]
[object Object]